Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 6Colonic Neoplasms 2Anus Neoplasms 2Rectal Neoplasms 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1HIV Infections 1Digestive System Diseases 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Anal Canal Carcinoma 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 16Cetuximab 13Leucovorin 12Fluorouracil 12Bevacizumab 10pembrolizumab 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 6Irinotecan 6Capecitabine 6encorafenib 4Pemetrexed 4Gemcitabine 4Cisplatin 4cemiplimab 3Folfox protocol 3Early Intervention, Educational 3Carboplatin 3Biopsy 3trifluridine tipiracil drug combination 2relatlimab 2pertuzumab 2palbociclib 2fludarabine 2durvalumab 2dehydroftorafur 2aldesleukin 2adagrasib 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Colonoscopy × 90 days × Clear all
NCT07502469 2026-03-31

BENEFIT

Elsan

Completed
341 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT07503847 2026-03-31

Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49

National Taiwan University Hospital

Phase NA Enrolling by invitation
2,286 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡